131 I-MIBG in Treating Patients With Refractory or Relapsed Neuroblastoma
|2||Temporarily not available||
A Compassionate Use/Expanded Access Protocol Using 131I-MIBG Therapy for Patients With Refractory Neuroblastoma and Metastatic Pheochromocytoma
|3||Not yet recruiting||
Phase I Study of Investigational Medicinal Products in Children With Relapsed/Refractory Neuroblastoma
† Study has passed its completion date and status has not been verified in more than two years.